Publications by authors named "Han-Ki Park"

Background: Limited understanding exists regarding the progression trajectory of severe eosinophilic asthma (SEA) patients on type 2 biologics therapies.

Objective: We aim to explore distinct longitudinal phenotypes of these patients based on crucial asthma biomarkers.

Methods: We enrolled 101 adult patients with SEA.

View Article and Find Full Text PDF

Purpose: Despite the emerging biologics, biomarkers and treatment options for asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) are still limited, requiring further research.

Methods: We enrolled 378 ACO patients from a multicenter real-world asthma cohort in Korea and compared the clinical characteristics, lung function, and exacerbation between type 2 (T2)-high and T2-low groups. We used the following comparisons: 1) low vs.

View Article and Find Full Text PDF

Background: Recently, cough reflex hypersensitivity has been proposed as a common underlying feature of chronic cough in adults. However, symptoms and clinical characteristics of cough hypersensitivity have not been studied amongst phenotypes of chronic cough. This study aimed to compare symptom features, such as cough triggers and associated throat sensations, of cough hypersensitivity in patients with asthmatic chronic cough and those with refractory chronic cough (RCC).

View Article and Find Full Text PDF

Background: Anti-type 2 (T2) biologic therapies (biologics) improve exacerbation rates, lung function, and asthma-related quality of life (QoL) in patients with severe T2 asthma. However, studies comparing different biologics are lacking. We evaluated the QoL in patients with severe asthma comprehensively and compare the efficacy of different T2-directed biologics using QoL questionnaires.

View Article and Find Full Text PDF

The diagnosis of anaphylaxis is based on the clinical history. The utility of tryptase measurements in clinical setting is limited. Mas-related G protein-coupled receptor-X2 (MRGPRX2) is expressed in mast cells and is involved in the degranulation of these cells.

View Article and Find Full Text PDF
Article Synopsis
  • - The study evaluated the effectiveness of codeine for treating chronic cough in patients who didn't respond to standard treatments, finding that about 40.7% had identifiable causes while the rest didn't.
  • - Out of 305 patients, only 16.7% experienced a quick and notable improvement with codeine, while 59.3% remained non-responsive after the treatment.
  • - The results highlight that although codeine helps some patients, the majority still struggle with chronic cough, emphasizing the need for developing new antitussive medications.
View Article and Find Full Text PDF

Background: The determinants linked to the short- and long-term improvement in lung function in patients with severe eosinophilic asthma (SEA) on biological treatment (BioT) remain elusive.

Objective: We sought to identify the predictors of early and late lung function improvement in patients with SEA after BioT.

Methods: 140 adult patients with SEA who received mepolizumab, dupilumab, or reslizumab were followed up for 6 months to evaluate improvement in forced expiratory volume in one second (FEV).

View Article and Find Full Text PDF

Background: Despite the increasing use of biologics in severe asthma, there is limited research on their use in asthma-chronic obstructive pulmonary disease overlap (ACO). We compared real-world treatment responses to biologics in ACO and asthma.

Methods: We conducted a multicenter, retrospective, cohort study using data from the Precision Medicine Intervention in Severe Asthma (PRISM).

View Article and Find Full Text PDF

Background: Carboplatin administration poses a risk of immediate hypersensitivity reactions (IHRs) that tend to increase with repeated administration and are mostly IgE-mediated.

Objective: This study evaluated the usefulness of carboplatin-prescreening intradermal skin tests (IDTs).

Methods: Carboplatin-prescreening IDTs were routinely conducted in patients with a history of receiving six or more carboplatin cycles beginning in January 2021.

View Article and Find Full Text PDF
Article Synopsis
  • A study was conducted to compare the effectiveness of three monoclonal antibodies—reslizumab, mepolizumab, and dupilumab—in treating severe eosinophilic asthma (SEA).
  • The analysis involved 141 SEA patients, looking at exacerbation rates, lung function, and asthma control over 12 months.
  • Results indicated that all three treatments led to similar clinical outcomes, with no significant differences between the drugs in managing asthma exacerbations and overall control.
View Article and Find Full Text PDF
Article Synopsis
  • A study assessed the best strategies to prevent hypersensitivity reactions (HSR) in patients with a history of immediate HSR to low-osmolar iodinated contrast media (LOCM), examining factors like premedication and LOCM substitutions.
  • The research included 3800 LOCM exposures in 1066 patients, finding that premedication with corticosteroids significantly reduced the chance of HSR recurrence, while using different LOCM without common side chains was notably effective.
  • The results emphasized that switching to alternative LOCM, especially those without shared side chains, significantly decreased HSR occurrences, particularly in patients who previously had moderate to severe reactions.
View Article and Find Full Text PDF
Article Synopsis
  • The Korean Chronic Cough Registry study aims to better understand patients with chronic cough (CC) by analyzing their profiles and treatment outcomes in real-world settings.
  • The study included 610 patients from 18 centers, revealing that a significant portion had a longer duration of cough, especially those with refractory or unexplained chronic cough (RUCC).
  • Findings indicate that chronic cough often starts in adulthood, lasts for years, and significantly impacts patients' quality of life, highlighting the need for better treatment methods and follow-up research.
View Article and Find Full Text PDF
Article Synopsis
  • An AI-based cough counting system was tested in a study involving patients experiencing acute asthma exacerbations, utilizing a smartphone app called Coughy to record cough sounds over a week.
  • The study involved 24 asthmatic patients, who recorded a total of 1,417.6 hours of cough, with the AI cough counts showing a strong correlation to manual counts by expert evaluators during both sleep and awake periods.
  • While AI cough counts related to various asthma-related factors like symptom severity and medication use, there was no significant correlation between cough counts and peak expiratory flow rate (PEFR).
View Article and Find Full Text PDF

Background: Iodinated contrast media (ICM) are a common cause of drug-induced immediate hypersensitivity reaction (IHR). Repeated use of ICM is often necessary; therefore, a standardized protocol to prevent recurrence of IHR is required.

Objective: We aimed to propose an intradermal skin test (IDT)-guided strategy for previous reactors to prevent recurrence of IHR.

View Article and Find Full Text PDF
Article Synopsis
  • The article has been withdrawn at the request of the authors or editor.
  • The publisher has apologized for any inconvenience caused by this withdrawal.
  • Readers can find more information on the full Elsevier Policy regarding article withdrawal at the provided link.
View Article and Find Full Text PDF

Purpose: Chronic cough (CC) is associated with health-related quality of life (HRQoL) impairment. However, the determinants of HRQoL are under-investigated.

Methods: Patients aged 19-80 years with CC were prospectively recruited from 10 referral clinics.

View Article and Find Full Text PDF

Background: Accumulating evidence suggests that the gut microbiome is associated with asthma. However, altered gut microbiome in adult asthma is not yet well established. We aimed to investigate the gut microbiome profiles of adult asthmatic patients with symptomatic eosinophilic inflammation.

View Article and Find Full Text PDF

Here we report a case of successful heart transplantation (HT) in a patient with high risk on HT due to her complex congenital heart disease and its consequent complications; physiologic single lung and severe pulmonary arterial hypertension. HT was successfully performed in our patient using meticulous perioperative management techniques, such as control of collateral vessels, appropriate donor selection, pulmonary vasodilator therapy, post-transplant extracorporeal membranous oxygenation support, and atrial septostomy for right ventricular unloading.

View Article and Find Full Text PDF

Growing evidence suggests that there is an essential link between the gut and lungs. Asthma is a common chronic inflammatory disease and is considered a heterogeneous disease. While it has been documented that eosinophilic asthma affects gut immunity and the microbiome, the effect of other types of asthma on the gut environment has not been examined.

View Article and Find Full Text PDF

Background And Aim: Current therapeutic strategies for infections (CDI), including oral vancomycin, metronidazole and fecal microbial transplantation, have limited efficacy and treatment failure may occur in as many as one- third of cases. Recent studies have reported that lower concentrations of 25-hydroxyvitamin D are associated with CDI severity and recurrence. However, there have been no studies on microbiota composition after the administration of vitamin D in patients with CDI.

View Article and Find Full Text PDF